Doctor invests in cancer AI he used during wife’s diagnosis

Dr. Munjal Shroff, an Atlanta psychiatrist, turned to Healz AI after his wife developed unexplained symptoms in the fall of 2025, including rashes, itching, fatigue, and swollen lymph nodes. The healthcare-focused chatbot helped organize information and urged the couple to seek another opinion at the University of Texas MD Anderson Cancer Center, a step Shroff said was crucial to her diagnosis of rare T-cell lymphoma.

Healz is designed to help cancer patients understand diagnoses, find oncologists, interpret tests, and navigate treatment and recovery while supplementing, not replacing, physicians. The startup uses existing models with its own memory system and workflows, including a feature that can process large medical files, with one user uploading 1,500 documents. Its root-cause mode asks up to 20 follow-up questions before offering suggestions.

The company is backed by Recursive Superintelligence cofounder Alexey Dosovitskiy, whose startup has raised over $650 million at a $4.65 billion valuation. Healz said recurring revenue doubled each month from June to August, reaching $100,000 in annual recurring revenue as of early September. Its user base is 97% cancer patients, and month-to-month user retention was 70%.

Shroff continued using Healz to discuss chemotherapy options and later became an investor. He said the system has occasionally been off on treatment specifics, making physician oversight essential, but called it an indispensable tool during his wife’s ongoing care.